CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Diosmin

地奥司明 杂质对照品Diosmin Impurities

EP43 个杂质条目43 impurity entries

本页汇总 地奥司明 的 43 个杂质对照品条目,其中药典杂质标注了 EP/USP 编号。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 43 impurity reference standards of Diosmin with EP/USP numbering where applicable. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 地奥司明(Diosmin)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 杂质研究Impurity studiesSimultaneous Determination of Diosmin and Hesperidin in Pharmaceuticals by RPLC using Ionic Liquids as Mobile Phase Modifiers
    Iranian journal of pharmaceutical research : IJPR · 2016 · Szymański M et al.  ·  PMID 27610154
  2. 杂质研究Impurity studiesDiosmin reduces the stability of Snail and Cyclin D1 by targeting FAK to inhibit NSCLC progression
    Phytomedicine : international journal of phytotherapy and phytopharmacology · 2024 · Ma C et al.  ·  PMID 39405613  ·  DOI
  3. 杂质研究Impurity studiesChemopreventive effects of diosmin and hesperidin on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary-bladder carcinogenesis in male ICR mice
    International journal of cancer · 1997 · Yang M et al.  ·  PMID 9398052  ·  DOI
  4. 分析方法Analytical MethodsSimultaneous determination of diosmin and hesperidin in combined pharmaceutical preparation by synchronous fluorescence spectrofluorimetric method
    Royal Society open science · 2024 · Askar H et al.  ·  PMID 39050722  ·  DOI

合成路线参考Reported synthetic routes

以下为公开文献中报道的合成方法(题录信息)。标题多已点明关键反应,可据此查阅原文了解完整路线与工艺条件。Published synthetic approaches. Titles usually name the key transformation; consult the original articles for full routes.

  • 合成方法SynthesisSynthesis of [ring B-13C6] diosmin
    Journal of natural products · 1990 · Dulcire B, Winternitz PF  ·  PMID 2213037  ·  DOI

地奥司明 —— 原料药与杂质对照品Diosmin — drug substance & impurities

共 44 个条目(含原料药本体)44 items incl. the drug substance
Diosmin structure
EP原料药 APIAPI
地奥司明Diosmin
Diosmin
CAS No.520-27-4
Chemical FormulaC28H32O15
Purity>95%询价On request
10mg25mg50mg100mg
Diosmin Impurity 1 (Diosmin EP Impurity A) structure
EPA
地奥司明杂质1(地奥司明EP杂质A)Diosmin Impurity 1 (Diosmin EP Impurity A)
Diosmin Impurity 1 (Diosmin EP Impurity A)
CAS No.6100-74-9
Chemical FormulaC9H10O3
Purity>95%询价On request
10mg25mg50mg100mg
Diosmin Impurity 3 (Diosmin EP Impurity C)(Isorhoifolin) structure
EPC
地奥司明杂质3 (地奥司明EP杂质C)(异野漆树苷)Diosmin Impurity 3 (Diosmin EP Impurity C)(Isorhoifolin)
Diosmin Impurity 3 (Diosmin EP Impurity C)(Isorhoifolin)
CAS No.552-57-8
Chemical FormulaC27H30O14
Purity>95%询价On request
10mg25mg50mg100mg
Diosmin Impurity 4 (Diosmin EP Impurity D)(6-Iodo Diosmin) structure
EPD
地奥司明杂质4(地奥司明EP杂质D)( 6-碘代地奥司明)Diosmin Impurity 4 (Diosmin EP Impurity D)(6-Iodo Diosmin)
Diosmin Impurity 4 (Diosmin EP Impurity D)(6-Iodo Diosmin)
CAS No.1431536-92-3
Chemical FormulaC28H31IO15
Purity>95%询价On request
10mg25mg50mg100mg
Diosmin Impurity 5 (Diosmin EP Impurity E) (Linarin) structure
EPE
地奥司明杂质5 (地奥司明EP杂质E) (蒙花苷)Diosmin Impurity 5 (Diosmin EP Impurity E) (Linarin)
Diosmin Impurity 5 (Diosmin EP Impurity E) (Linarin)
CAS No.480-36-4
Chemical FormulaC28H32O14
Purity>95%询价On request
10mg25mg50mg100mg
Diosmin Impurity 6 (Diosmin EP Impurity F)(Diosmetin) structure
EPF
地奥司明杂质6(地奥司明EP杂质F)( 香叶木素)Diosmin Impurity 6 (Diosmin EP Impurity F)(Diosmetin)
Diosmin Impurity 6 (Diosmin EP Impurity F)(Diosmetin)
CAS No.520-34-3
Chemical FormulaC16H12O6
Purity>95%询价On request
10mg25mg50mg100mg
Diosmin Impurity 7 (Diosmin EP Impurity G) (rac-Hesperetin) structure
EPG
地奥司明杂质7(地奥司明EP杂质G)(rac-橙皮素)Diosmin Impurity 7 (Diosmin EP Impurity G) (rac-Hesperetin)
Diosmin Impurity 7 (Diosmin EP Impurity G) (rac-Hesperetin)
CAS No.520-33-2
Chemical FormulaC16H14O6
Purity>95%询价On request
10mg25mg50mg100mg
Diosmin Impurity 6-d3 (Diosmin EP Impurity F-d3)(Diosmetin-d3) structure
EPF-D3
地奥司明杂质6-d3 (地奥司明EP杂质F-d3)( 香叶木素-d3)Diosmin Impurity 6-d3 (Diosmin EP Impurity F-d3)(Diosmetin-d3)
Diosmin Impurity 6-d3 (Diosmin EP Impurity F-d3)(Diosmetin-d3)
CAS No.1189728-54-8
Chemical FormulaC16H9D3O6
Purity>95%询价On request
Diosmin Impurity 6-13C,d3 (Diosmin EP Impurity F-13C,d3)(Diosmetin-13C,d3) structure
EPF-13C
地奥司明杂质6-13C,d3 (地奥司明EP杂质F-13C,d3)( 香叶木素-13C,d3)Diosmin Impurity 6-13C,d3 (Diosmin EP Impurity F-13C,d3)(Diosmetin-13C,d3)
Diosmin Impurity 6-13C,d3 (Diosmin EP Impurity F-13C,d3)(Diosmetin-13C,d3)
CAS No.1261394-22-2
Chemical FormulaC1513CH9D3O6
Purity>95%询价On request
10mg25mg50mg100mg
Diosmin Impurity 8 (Didymin) structure
8
地奥司明杂质8 (香风草甙)Diosmin Impurity 8 (Didymin)
Diosmin Impurity 8 (Didymin)
CAS No.14259-47-3
Chemical FormulaC28H34O14
Purity>95%询价On request
10mg25mg50mg100mg
Diosmin Impurity 9 structure
9
地奥司明杂质9Diosmin Impurity 9
Diosmin Impurity 9
CAS No.2418540-64-2
Chemical FormulaC28H34O14
Purity>95%询价On request
10mg25mg50mg100mg
Diosmin Impurity 10 structure
10
地奥司明杂质10Diosmin Impurity 10
Diosmin Impurity 10
CAS No.645-08-9
Chemical FormulaC8H8O4
Purity>95%询价On request
10mg25mg50mg100mg
Diosmin Impurity 11 structure
11
地奥司明杂质11Diosmin Impurity 11
Diosmin Impurity 11
CAS No.20126-59-4
Chemical FormulaC22H22O11
Purity>95%询价On request
10mg25mg50mg100mg
Diosmin Impurity 14 structure
14
地奥司明杂质14Diosmin Impurity 14
Diosmin Impurity 14
CAS No.34280-05-2
Chemical FormulaC29H34O15
Purity>95%询价On request
10mg25mg50mg100mg
Diosmin Impurity 15 structure
15
地奥司明杂质15Diosmin Impurity 15
Diosmin Impurity 15
CAS No.122087-66-5
Chemical FormulaC30H38O15
Purity>95%询价On request
10mg25mg50mg100mg
Diosmin Impurity 16 structure
16
地奥司明杂质16Diosmin Impurity 16
Diosmin Impurity 16
CAS No.38302-15-7
Chemical FormulaC18H18O5
Purity>95%询价On request
10mg25mg50mg100mg
Diosmin Impurity 17 structure
17
地奥司明杂质17Diosmin Impurity 17
Diosmin Impurity 17
CAS No.89294-54-2
Chemical FormulaC17H16O6
Purity>95%询价On request
10mg25mg50mg100mg
Diosmin Impurity 18 structure
18
地奥司明杂质18Diosmin Impurity 18
Diosmin Impurity 18
CAS No.28719-21-3
Chemical FormulaC30H38O15
Purity>95%询价On request
10mg25mg50mg100mg
Diosmin Impurity 19 structure
19
地奥司明杂质19Diosmin Impurity 19
Diosmin Impurity 19
CAS No.67549-69-3
Chemical FormulaC21H24O8
Purity>95%询价On request
10mg25mg50mg100mg
Diosmin Impurity 20 (Diosmin Octaacetate) structure
20
地奥司明杂质20(香风草甙八乙酸酯)Diosmin Impurity 20 (Diosmin Octaacetate)
Diosmin Impurity 20 (Diosmin Octaacetate)
CAS No.6195-54-6
Chemical FormulaC44H48O23
Purity>95%询价On request
10mg25mg50mg100mg
Diosmin Impurity 21 (Narirutin) structure
21
地奥司明杂质21 (芸香柚皮苷)Diosmin Impurity 21 (Narirutin)
Diosmin Impurity 21 (Narirutin)
CAS No.14259-46-2
Chemical FormulaC27H32O14
Purity>95%询价On request
10mg25mg50mg100mg
Diosmin Impurity 22 structure
22
地奥司明杂质22Diosmin Impurity 22
Diosmin Impurity 22
CAS No.69097-99-0
Chemical FormulaC16H14O6
Purity>95%询价On request
10mg25mg50mg100mg
Diosmin Impurity 23 structure
23
地奥司明杂质23Diosmin Impurity 23
Diosmin Impurity 23
CAS No.22888-70-6
Chemical FormulaC25H22O10
Purity>95%询价On request
10mg25mg50mg100mg
Diosmin Impurity 24 (Isosilybin) structure
24
地奥司明杂质24 (异水飞蓟宾)Diosmin Impurity 24 (Isosilybin)
Diosmin Impurity 24 (Isosilybin)
CAS No.72581-71-6
Chemical FormulaC25H22O10
Purity>95%询价On request
10mg25mg50mg100mg
Diosmin Impurity 25 structure
25
地奥司明杂质25Diosmin Impurity 25
Diosmin Impurity 25
CAS No.33889-69-9
Chemical FormulaC25H22O10
Purity>95%询价On request
10mg25mg50mg100mg
Diosmin Impurity 26 structure
26
地奥司明杂质26Diosmin Impurity 26
Diosmin Impurity 26
CAS No.29782-68-1
Chemical FormulaC25H22O10
Purity>95%询价On request
10mg25mg50mg100mg
Diosmin Impurity 29 structure
29
地奥司明杂质29Diosmin Impurity 29
Diosmin Impurity 29
CAS No.108815-81-2
Chemical FormulaC27H32O14
Purity>95%询价On request
10mg25mg50mg100mg
Diosmin Impurity 30 structure
30
地奥司明杂质30Diosmin Impurity 30
Diosmin Impurity 30
CAS No.1313494-49-3
Chemical FormulaC28H33IO15
Purity>95%询价On request
10mg25mg50mg100mg
Diosmin Impurity 31 (Eriocitrin) structure
31
地奥司明杂质31 (圣草次甙)Diosmin Impurity 31 (Eriocitrin)
Diosmin Impurity 31 (Eriocitrin)
CAS No.13463-28-0
Chemical FormulaC27H32O15
Purity>95%询价On request
10mg25mg50mg100mg
Diosmin Impurity 32 structure
32
地奥司明杂质32Diosmin Impurity 32
Diosmin Impurity 32
CAS No.906320-90-9
Chemical FormulaC27H32O14
Purity>95%询价On request
10mg25mg50mg100mg
Diosmin Impurity 33 structure
33
地奥司明杂质33Diosmin Impurity 33
Diosmin Impurity 33
CAS No.152312-71-5
Chemical FormulaC8H7O4-·K+
Purity>95%询价On request
10mg25mg50mg100mg
Diosmin Impurity 34 structure
34
地奥司明杂质34Diosmin Impurity 34
Diosmin Impurity 34
CAS No.19993-32-9
Chemical FormulaC22H22O11
Purity>95%询价On request
10mg25mg50mg100mg
Diosmin Impurity 35 structure
35
地奥司明杂质35Diosmin Impurity 35
Diosmin Impurity 35
CAS No.152503-50-9
Chemical FormulaC22H20O12
Purity>95%询价On request
10mg25mg50mg100mg
Diosmin Impurity 36 structure
36
地奥司明杂质36Diosmin Impurity 36
Diosmin Impurity 36
CAS No.1237479-09-2
Chemical FormulaC22H22O12
Purity>95%询价On request
10mg25mg50mg100mg
Diosmin Impurity 37 structure
37
地奥司明杂质37Diosmin Impurity 37
Diosmin Impurity 37
CAS No.6906-38-3
Chemical FormulaC21H21O12+·Cl-
Purity>95%询价On request
10mg25mg50mg100mg
Diosmin Impurity 38 structure
38
地奥司明杂质38Diosmin Impurity 38
Diosmin Impurity 38
CAS No.15674-58-5
Chemical FormulaC27H31O16+·Cl-
Purity>95%询价On request
10mg25mg50mg100mg
Diosmin Impurity 39 structure
39
地奥司明杂质39Diosmin Impurity 39
Diosmin Impurity 39
CAS No.24604-97-5
Chemical FormulaC16H14O6
Purity>95%询价On request
10mg25mg50mg100mg
Diosmin Impurity 41 (Hesperetin 7-O-glucoside) structure
41
地奥司明杂质41 (橙皮素7 - O -葡萄糖苷)Diosmin Impurity 41 (Hesperetin 7-O-glucoside)
Diosmin Impurity 41 (Hesperetin 7-O-glucoside)
CAS No.31712-49-9
Chemical FormulaC22H24O11
Purity>95%询价On request
10mg25mg50mg100mg
Diosmin Impurity 42(Hesperetin 7-O-β-D-glucopyranoside) structure
42
地奥司明杂质42 (橙皮素7-O-β-D-吡喃葡萄糖苷)Diosmin Impurity 42(Hesperetin 7-O-β-D-glucopyranoside)
Diosmin Impurity 42(Hesperetin 7-O-β-D-glucopyranoside)
CAS No.906320-94-3
Chemical FormulaC22H24O11
Purity>95%询价On request
10mg25mg50mg100mg
Diosmin Impurity 44 structure
44
地奥司明杂质44Diosmin Impurity 44
Diosmin Impurity 44
CAS No.172805-78-6
Chemical FormulaC20H20O8
Purity>95%询价On request
10mg25mg50mg100mg
Diosmin Impurity 45 Sodium Salt structure
45
地奥司明杂质45 钠盐Diosmin Impurity 45 Sodium Salt
Diosmin Impurity 45 Sodium Salt
CAS No.63240-72-2
Chemical FormulaC16H13O9S-·Na+
Purity>95%询价On request
10mg25mg50mg100mg
Diosmin Impurity 45 structure
45
地奥司明杂质45Diosmin Impurity 45
Diosmin Impurity 45
CAS No.756763-72-1
Chemical FormulaC16H14O9S
Purity>95%询价On request
10mg25mg50mg100mg
Diosmin Impurity 46 (Chrysoeriol-4-O-Glucuronide) structure
46
地奥司明杂质46 (金圣草黄素-4-O-葡萄糖醛酸苷)Diosmin Impurity 46 (Chrysoeriol-4-O-Glucuronide)
Diosmin Impurity 46 (Chrysoeriol-4-O-Glucuronide)
CAS No.1714992-41-2
Chemical FormulaC22H20O12
Purity>95%询价On request
10mg25mg50mg100mg
Diosmin Impurity 47 (Diosmetin 7-O-β-D-Glucuronide) structure
47
地奥司明杂质47 (香叶木素 7-O-Β-D-葡萄糖醛酸苷)Diosmin Impurity 47 (Diosmetin 7-O-β-D-Glucuronide)
Diosmin Impurity 47 (Diosmetin 7-O-β-D-Glucuronide)
CAS No.35110-20-4
Chemical FormulaC22H20O12
Purity>95%询价On request
10mg25mg50mg100mg

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

地奥司明 —— 研究文献与合成路线Diosmin — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 地奥司明 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Diosmin. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. Improved LC methods for the determination of diosmin and/or hesperidin in plant extracts and pharmaceutical formulations
    El-Shafae AM, El-Domiaty MM · Journal of pharmaceutical and biomedical analysis · 2001 · 被引 31cited 31
  2. Simultaneous reversed-phase high-performance liquid chromatographic method for the determination of diosmin, hesperidin and naringin in different citrus fruit juices and pharmaceutical formulations
    Kanaze FI, Gabrieli C, Kokkalou E, et al. · Journal of pharmaceutical and biomedical analysis · 2003 · 被引 73cited 73
  3. Use of multiresponse statistical techniques to optimize the separation of diosmin, hesperidin, diosmetin and hesperitin in different pharmaceutical preparations by high performance liquid chromatography with UV-DAD
    Sammani MS, Clavijo S, Portugal L, et al. · Talanta · 2017 · 被引 12cited 12
  4. Determination of trace levels of diosmin in a pharmaceutical preparation by adsorptive stripping voltammetry at a glassy carbon electrode
    El-Shahawi MS, Bashammakh AS, El-Mogy T · Analytical sciences : the international journal of the Japan Society for Analytical Chemistry · 2006 · 被引 13cited 13
  5. Determination of Diosmin in Pharmaceutical Products with Chemically Modified Voltammetric Sensors
    Gunache Roșca RO, Apetrei C · International journal of molecular sciences · 2021 · 被引 3cited 3
  6. Simultaneous determination of diosmin and hesperidin in combined pharmaceutical preparation by synchronous fluorescence spectrofluorimetric method
    Askar H, Fathy ME, Tolba MM, et al. · Royal Society open science · 2024 · 被引 1cited 1

合成与制备工艺专利Synthesis & process patents

  1. PROCESS FOR THE PREPARATION OF DIOSMIN
    SAKHARDANDE RAJIV, NIMBALKAR MANMOHAN, KHATRI NAVIN, PATIL SUBARAO, et al. · 公开号 WO2010092592WO2010092592 · 2010
  2. Diosmin producing process
    GUANGYUE ZHANG, QIANG ZHANG · 公开号 CN101089009CN101089009 · 2007
  3. Novel lyophilised form of diosmin and its preparation
    ANNE COUTEL, MICHEL VEILLARD · 公开号 FR2661610FR2661610 · 1991

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

地奥司明 杂质谱研究要点Diosmin — impurity profiling notes

下面这些是拿到 地奥司明 的 44 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 44 impurity entries for Diosmin, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

本品种含药典编号杂质(EP/USP)。申报时药典已收载的杂质通常需要逐项对照,建议优先备齐药典编号对照品,再补充工艺与降解杂质。This drug substance includes pharmacopoeially designated impurities (EP/USP). Monographed impurities normally need item-by-item comparison during filing, so secure the pharmacopoeial standards first, then fill in process and degradation impurities.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances